Antimicrobial Peptide CM11 Combined with Zoledronic Acid Creates a Bone Scaffold That Both Grows Bone and Fights Infection

Bioactive glass/gelatin scaffolds loaded with CM11 antimicrobial peptide and zoledronic acid demonstrated both enhanced osteogenic stem cell differentiation and antimicrobial activity against MDR bacteria.

In vitro study synthesizing BG/Gel composites via sol-gel method, loading with CM11 peptide and zoledronic acid. Characterized by FTIR, SEM, and disk diffusion. Stem cell differentiation assessed by MTT, calcium/ALP assays, immunocytochemistry for osteocalcin, and RT-PCR for osteoblast markers.

Post-surgical bone infections by drug-resistant bacteria are devastating and difficult to treat. A scaffold that simultaneously regrows bone and prevents infection could dramatically improve outcomes for patients needing bone reconstruction or implants.

Dual-function biomaterials — combining tissue regeneration with antimicrobial protection — represent the next generation of orthopedic implants. Using antimicrobial peptides instead of traditional antibiotics addresses resistance concerns while the peptide integrates naturally into the scaffold.

In vitro study only — no animal model testing of scaffold performance. Long-term peptide release kinetics and scaffold degradation not fully characterized. Clinical translation requires animal studies for biocompatibility and mechanical strength. Only tested against two bacterial species.